These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33605149)

  • 1. Substantial HbA1c Reduction Following Intermittent-Scanning Continuous Glucose Monitoring Was Not Associated With Early Worsening of Retinopathy in Type 1 Diabetes.
    Linton K; Stimson RH; Dover AR; Forbes S; Madill K; Annoh R; Strachan MWJ; McKnight JA; Wright RJ; Gibb FW
    J Diabetes Sci Technol; 2022 Jul; 16(4):921-928. PubMed ID: 33605149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HbA1c reduction following flash monitoring commencement is not independently associated with adverse diabetic eye disease outcomes in type 1 diabetes.
    Al-Dalla Ali M; Stimson RH; Dover AR; Forbes S; Annoh R; Madill K; Gibb FW
    BMJ Open Diabetes Res Care; 2020 Nov; 8(2):. PubMed ID: 33132212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HbA
    Lind M; Pivodic A; Svensson AM; Ólafsdóttir AF; Wedel H; Ludvigsson J
    BMJ; 2019 Aug; 366():l4894. PubMed ID: 31462492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin.
    Reid LJ; Gibb FW; Colhoun H; Wild SH; Strachan MWJ; Madill K; Dhillon B; Forbes S
    Diabetologia; 2021 Aug; 64(8):1725-1736. PubMed ID: 33966091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term risk of severe retinopathy in childhood-onset type 1 diabetes: a data linkage study.
    White M; Sabin MA; Magnussen CG; O'Connell MA; Colman PG; Cameron F
    Med J Aust; 2017 May; 206(9):398-401. PubMed ID: 28490305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial.
    Arch Ophthalmol; 1998 Jul; 116(7):874-86. PubMed ID: 9682700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What may be gained from standard photocoagulation during early worsening of diabetic retinopathy? An observational study in type-1 diabetic patients after tightening of glycaemic control.
    Chantelau E
    Diabetes Metab; 2001 Jun; 27(3):366-71. PubMed ID: 11431602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes.
    Feldman-Billard S; Larger É; Massin P;
    Diabetes Metab; 2018 Feb; 44(1):4-14. PubMed ID: 29217386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early risk stratification in pediatric type 1 diabetes.
    Broe R
    Acta Ophthalmol; 2015 Mar; 93 Thesis 1():1-19. PubMed ID: 25703648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-world Population-Based Study in Subjects With Type 2 Diabetes.
    Simó R; Franch-Nadal J; Vlacho B; Real J; Amado E; Flores J; Mata-Cases M; Ortega E; Rigla M; Vallés JA; Hernández C; Mauricio D
    Diabetes Care; 2023 Sep; 46(9):1633-1639. PubMed ID: 37428631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Fast-Acting Insulin Aspart on Glycemic Control in Patients with Type 1 Diabetes Using Intermittent-Scanning Continuous Glucose Monitoring Within a Real-World Setting: The GoBolus Study.
    Danne T; Axel Schweitzer M; Keuthage W; Kipper S; Kretzschmar Y; Simon J; Wiedenmann T; Ziegler R
    Diabetes Technol Ther; 2021 Mar; 23(3):203-212. PubMed ID: 32924568
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial.
    Lachin JM; Bebu I; Gao X; Nathan DM; Zinman B;
    Diabetes Care; 2022 Oct; 45(10):2445-2448. PubMed ID: 35972222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of retinopathy in patients with type 1 diabetes treated with education-based intensified insulin therapy and its association with parameters of glucose control.
    Hatz K; Minder AE; Lehmann R; Drescher T; Gerendas B; Schmidt-Erfurth U; Kaider A; Pruente C; Zulewski H
    Diabetes Res Clin Pract; 2019 Feb; 148():234-239. PubMed ID: 30684505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Follow-up of the Berlin Retinopathy Study.
    Danne T; Weber B; Hartmann R; Enders I; Burger W; Hovener G
    Diabetes Care; 1994 Dec; 17(12):1390-6. PubMed ID: 7882807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HbA1c response and hospital admissions following commencement of flash glucose monitoring in adults with type 1 diabetes.
    Stimson RH; Dover AR; Ritchie SA; Wright RJ; McKnight JA; Zammitt NN; Gibb FW
    BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32719078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked improvement in HbA
    Tyndall V; Stimson RH; Zammitt NN; Ritchie SA; McKnight JA; Dover AR; Gibb FW
    Diabetologia; 2019 Aug; 62(8):1349-1356. PubMed ID: 31177314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Text-message responsiveness to blood glucose monitoring reminders is associated with HbA
    McGill DE; Volkening LK; Butler DA; Wasserman RM; Anderson BJ; Laffel LM
    Diabet Med; 2019 May; 36(5):600-605. PubMed ID: 30734361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.
    Ann Intern Med; 1998 Apr; 128(7):517-23. PubMed ID: 9518395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.